Mutations on BLM and the TRR (TOP3A/RMI1/RMI2) subcomplex have been linked to Bloom syndrome (BS) or BS-like genetic disorders, predisposing individuals to cancer development13,14. This evidence concerns the gene RMI1 and Bloom syndrome.